PeerVoice is committed to producing and distributing evidence-based, independently-created medical education in Heart & Lung that is designed to positively impact patient care. Activities can either be accredited or non-accredited but are always driven by the learning and practice needs of healthcare professionals. Learn more at: https://peervoice.com.
Giannis Mountzios, MD, PhD - Preparing to Turn Potential Into Progress in ES-SCLC: The Practicalities of DLL3-Targeted T-Cell Engagers
For the complete activity, including supporting material, please visit https://www.peervoice.com/EMH860. Presented by Giannis Mountzios, MD, PhD. Learning Objectives: Recall the results of pivotal clinical trials evaluating the role of Delta-like ligand 3 (DLL3)-targeted T-cell engagers in the treatment of extensive-stage small-cell lung cancer (ES-SCLC); Identify patients presenting with progressive ES-SCLC who may benefit from treatment with a DLL3-targeted therapy; Provide DLL3-targeted therapy appropriately, considering factors such as timing of dosing and recommended premedication and step-up dosing approaches; Recall symptoms, incidence, and time of onset associated with treatment-related adverse events observed in patients receiving DLL3-targeted therapy, including cytokine release syndrome (CRS) and immune effector cell-associated neurotoxicity syndrome (ICANS); Apply recommended mitigation and management strategies for CRS, ICANS, and/or other potential AEs associated with the use of DLL3-targeted T-cell engagers.
20 Jul 2026
Kausik Ray, MD, MPhil (Cantab), FMedSci - Altering the Disease Trajectory in Patients With and at High Risk of Atherosclerotic Cardiovascular Disease: Ensuring Best Practices for Identification and Management
For the complete activity, including supporting material, please visit https://www.peervoice.com/VUR860. Presented by Kausik Ray, MD, MPhil (Cantab), FMedSci. Learning Objectives: Discuss the rationale and importance of earlier recognition of patients with and at high risk of atherosclerotic cardiovascular disease (ASCVD); Identify key features associated with high-risk ASCVD; Apply practical strategies for achieving effective lipid control in individuals at high risk of ASCVD.
29 Jun 2026
Carel le Roux, MBChB, MSc, PhD - Beyond BMI: Transforming Modern Weight Management for Heart, Kidney, and Metabolic Health
For the complete activity, including supporting material, please visit https://www.peervoice.com/VAC860. Presented by Carel le Roux, MBChB, MSc, PhD; Biykem Bozkurt, MD, PhD; Domenica M. Rubino, MD; and Michael Donnelly-Boylen, MS. Learning Objectives: Describe the pathophysiologic relationship between obesity, metabolic dysfunction, and end-organ injury across cardiovascular, renal, and metabolic disease; Evaluate key clinical and psychosocial factors that influence multidisciplinary management decisions for patients with obesity and related cardiovascular-renal-metabolic disease; Apply evidence-based strategies to initiate and coordinate holistic, long-term weight management plans integrating nutrition, physical activity, behavioral, and pharmacologic interventions; Interpret the evolving rationale and design of emerging therapeutic approaches that target obesity as a root cause of multi-organ disease.
Who has been a guest on PeerVoice Heart & Lung Video
Names identified in recent episode analyses. Showing up to five guests.
Marianna Fontana MD PhD
Julian Gillmore MD PhD FRCP FRCPath
Nicoletta Policek
Yves Robitaille, MD, CSPQ, DABOM
Podcast Authority Score: 18 / 100
A composite of feed quality, social presence, YouTube performance and engagement. Read the methodology.
Quality
22
Social presence
0
YouTube
0
Engagement
32
Host of PeerVoice Heart & Lung Video?
Claim your podcast to manage its listing and keep your show details accurate.
Pod Engine is an independent podcast discovery and analytics service and is not affiliated with or endorsed by this podcast. Artwork and show content belong to their owners. Full legal notice.
Explore this show Podcast research with Pod Engine
